Thrombosis on the damaged or ruptured vascular wall in a stenotic coronary artery is believed to be the precipitating factor leading to unstable angina. Little is known about the nature of the interactions among platelets, fluid dynamic factors, and vessel wall properties under such conditions. In the present investigation we have compared two experimental models of thrombosis simultaneously in anesthetized dogs. The first was an in vivo model of unstable angina, in which a fixed circumflex coronary artery stenosis was produced and the resultant cyclic blood flow reductions (CFRs) through the vessel were investigated after infusion of aspirin and a combination of aspirin and epinephrine. As previously reported, aspirin inhibited the CFRs, but the continuous infusion of epinephrine reestablished the appearance of CFRs. The second was an ex vivo model, in which thrombus formation on a type III collagen surface was investigated in a parallel-plate perfusion system under controlled conditions of exposure time and flow; morphological evaluation of thrombus volume, platelet adhesion, and fibrin deposition was performed. The chamber was positioned in an extracorporeal shunt between the carotid artery and the jugular vein of anesthetized dogs and exposed to nonanticoagulated blood at a shear rate of 1,600 sec" 1 . Thirty minutes after establishment of the CFRs, a blood sample for platelet aggregation was collected and a bleeding time and a first ex vivo perfusion were performed. At the end of this perfusion, animals were subjected either to no treatment (n=10) or to an intravenous bolus of 10 nig/kg aspirin (n=7), and a second perfusion was conducted 30 minutes later. Additional untreated animals (n=6) were given aspirin followed by a continuous intravenous infusion gation of the circulating platelets and release of thromboxane A 2 and serotonin, which are potent vasoconstrictors and platelet activators.
Effect of Aspirin and Epinephrine on Experimentally Induced Thrombogenesis in Dogs A Parallelism Between In Vivo and Ex Vivo Thrombosis Models
Sebastien P. Roux, Kjell S. Sakariassen, Vincent T. Turitto, and Hans R. Baumgartner Thrombosis on the damaged or ruptured vascular wall in a stenotic coronary artery is believed to be the precipitating factor leading to unstable angina. Little is known about the nature of the interactions among platelets, fluid dynamic factors, and vessel wall properties under such conditions. In the present investigation we have compared two experimental models of thrombosis simultaneously in anesthetized dogs. The first was an in vivo model of unstable angina, in which a fixed circumflex coronary artery stenosis was produced and the resultant cyclic blood flow reductions (CFRs) through the vessel were investigated after infusion of aspirin and a combination of aspirin and epinephrine. As previously reported, aspirin inhibited the CFRs, but the continuous infusion of epinephrine reestablished the appearance of CFRs. The second was an ex vivo model, in which thrombus formation on a type III collagen surface was investigated in a parallel-plate perfusion system under controlled conditions of exposure time and flow; morphological evaluation of thrombus volume, platelet adhesion, and fibrin deposition was performed. The chamber was positioned in an extracorporeal shunt between the carotid artery and the jugular vein of anesthetized dogs and exposed to nonanticoagulated blood at a shear rate of 1,600 sec" 1 . Thirty minutes after establishment of the CFRs, a blood sample for platelet aggregation was collected and a bleeding time and a first ex vivo perfusion were performed. At the end of this perfusion, animals were subjected either to no treatment (n=10) or to an intravenous bolus of 10 nig/kg aspirin (n=7), and a second perfusion was conducted 30 minutes later. Additional untreated animals (n=6) were given aspirin followed by a continuous intravenous infusion of 10 Few models have been developed for exploring the nature of the fluid dynamic, vascular, and bloodrelated mechanisms in vessels that are severely atherosclerotic; thus, systems to test interventional drug therapy are limited. One test that has become broadly accepted as a model of unstable angina induces a severe coronary stenosis by external mechanical constriction of the vessel wall. 8 The resultant vascular damage and narrowing produce cyclical blood flow reductions (CFRs) due to temporary blockage of the vascular lumen by thrombotic material, predominantly consisting of platelets. The reduction in flow has been shown to be inhibited by aspirin, an antiplatelet compound that has proved effective in various animal models of arterial thrombosis 89 and in clinical trials of unstable angina.
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In this model described by Folts et al, 8 aspirin inhibition can be overcome by a continuous infusion of epinephrine. 13 Although the model appears useful for the testing of various drug therapies, little control of experimental variables such as local flow conditions, extent, stenosis morphology, and properties of the thrombogenic surface is possible. In addition, detailed evaluation of the thrombotic deposits requires termination of the experiment and is extremely time consuming.
To overcome these drawbacks, we have developed an ex vivo perfusion chamber device 14 in which the local flow conditions and composition of the reactive surface are well controlled. The perfusion system offers the possibility of multiple uses in a single animal experiment, as well as the possibility of modifying surface or blood properties under conditions in which surface deposits of platelets and fibrin can be directly quantified by morphometry. 1516 In the present study we found that the two experimental settings gave comparable results with respect to the modulating effect of aspirin and epinephrine on the thrombotic response.
Methods

Animals
Twenty-two adult German shepherd dogs (25-30 kg) of either sex were used for the study. Seventeen dogs served for ex vivo and in vivo thrombosis experiments. In five additional dogs, histological examination of the stenosed coronary artery was performed.
Surgical Procedures
Dogs were anesthetized with sodium pentobarbital (30 mg/kg i.v.) and ventilated with room air by a Roche respirator (model 3100) at a rate of 18 inflations/min with a volume of 8 1/min. Tidal volume and respiratory rate were adjusted to maintain blood gases and pH within physiological limits. Arterial and venous femoral catheters were inserted for blood pressure measurement (Millar 5F microtip, Houston, Tex.) and drug administration. After a left thoracotomy in the fifth intercostal space was performed, the heart was suspended in a pericardial cradle. A Millar 5F pressure transducer was inserted into the left ventricular apex to obtain maximum peak dP/dt, the first positive left ventricular pressure derivative. Three centimeters of the proximal circumflex coronary artery was dissected free from surrounding tissue, and collaterals were ligated if present. Phasic and mean coronary flows were measured by an electromagnetic flow probe (Skalar, Delft, The Netherlands) positioned on the proximal portion of the vessel. All parameters, including the electrocardiogram, were recorded on a six-channel Hellige recorder (Hellige, Freiburg, FRG). A snare ligature was placed on the distal end of the vessel to determine zero flow and to produce reactive hyperemic responses within 20 seconds of occlusion. Before placement of a plastic occluder around the artery, the endothelium of the dissected coronary artery was damaged by squeezing the artery with a forceps five times, 5 seconds. Vessels were constricted by use of a plastic cylinder placed around the artery; the diameter of the constricting device was chosen such that a reactive hyperemic response to occlusion was abolished.
Constriction was produced as previously described with the help of a tapered fishline inserted between the obstructing cylinder and the vessel wall. 13 As previously described, obstruction must be very severe to obtain CFRs of zero flow. 17 Spontaneous dislodgement of the thrombus was rarely seen unless aspirin was given. When flow approached zero, a gentle shaking of the occluder broke loose the occlusive thrombus and restored coronary flow. CFRs were quantified by the slope of this decline in milliliters per minute squared.
Design of the Study
In vivo and ex vivo thromboses were investigated simultaneously in 17 dogs. In a first group of dogs (n = 10), we established that the recurrent thrombotic response exhibited by both systems remained stable for at least 1 hour, as follows. As soon as the CFRs were established and remained stable for 30 minutes, a first ex vivo perfusion was performed. At this time a 20-ml blood sample for platelet count, hematocrit, and in vitro platelet aggregation studies was collected. Platelet aggregation was performed with platelet-rich plasma anticoagulated with 20 mM trisodium citrate, with collagen (Horm collagen, Hormon-Chemie, Munchen, FRG) and ADP (Sigma Chemical Co., St. Louis, Mo.) as agonists. Template bleeding time was performed in duplicate by a standard incision in the dog's ear of about 2 mm deep and 10 mm long (Feather blood lancet, Tokyo, Japan). Approximately 30 minutes after the end of the first perfusion, a second ex vivo perfusion, bleeding time, and in vitro platelet aggregation were performed. At the end of the second perfusion, a subgroup of six dogs was given an intravenous bolus injection of 10 mg/kg aspirin (which immediately abolished the CFRs), followed by a 10-minute intravenous perfusion of epinephrine (10 )u,g/min). A third perfusion was conducted 10 minutes later. 
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In a second group of dogs (n=7), an intravenous bolus injection of 10 mg/kg aspirin (Aspegic, Kramer, Synthelabo, Lausanne, Switzerland) was given after the first perfusion, and a second perfusion was conducted 20 minutes later (see Figure 1 ).
Chamber for Ex Vivo Perfusions
A parallel-plate perfusion chamber 14 with a plastic coverslip (18x22x0.18 mm, Thermanox, Miles Laboratories Inc., Naperville, 111.) coated with purified human type III collagen was used as described below for ex vivo perfusions. The rectangular flow slit was 5.0 mm wide and 0.28 mm high.
Human Type III Fibrillar Collagen
Purification, fibril formation, and characterization of type III collagen have been recently reported. 10 The final preparation is more than 95% pure and aggregates blood platelets maximally at 3-4 ^.g/ml but does not initiate intrinsic or extrinsic coagulation. The fibrillar collagen was spray coated with an artist's air brush 18 onto washed Thermanox coverslips at an N 2 operating pressure of 1 atm to a final density of about 20 fig/cm 2 , as previously described.
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Ex Vivo Perfusions Ex vivo perfusions were performed with the perfusion chamber positioned in a shunt between the carotid artery and the jugular vein. The blood flow rate in the shunt was kept constant at 6.15 ml/min by a pump positioned distally to the chamber. The shear rate produced at the collagen surface was 1,600 sec"
Perfusions were performed for 5 minutes at 30, 60, and 70 minutes after onset of the CFRs. After each blood perfusion the chamber was disconnected distally, and a 20-second perfusion with buffer consisting of 130 mM NaCl, 2 mM KC1, 12 mM NaHCO 3 , 2.5 mM CaCl 2 , and 0.9 mM MgCl 2 [pH 7.4], followed by a 40-second perfusion with 2.5% glutaraldehyde/ 0.1 M cacodylate [pH 7.4] at the same shear rate, was conducted. The coverslip with the partially fixed thrombotic deposits was removed from the chamber, postfixed in cacodylate-buffered glutaraldehyde, and subsequently embedded in Epon. 19 
Morphometric Determination of Thrombotic Ex Vivo Deposits
Semithin sections for light-microscopic morphometry of platelet-surface and fibrin-surface interac- MAP, mean arterial pressure; HR, heart rate; dP/dt, first positive derivative of left ventricular pressure; CBF, mean coronary blood flow; CFR, presence (+) or absence (-) of coronary cyclic blood flow reductions (CFRs); ASA, aspirin; NV, no value given because of irregular peak and trough flow. *Only this condition had no coronary stenosis. tp<0.01, ip<0.05, compared before chamber 1. tions were prepared from Epon-embedded preparations at an axial position of 1 mm downstream from the flow inlet at the coverslip and perpendicular to the direction of blood flow. 20 The interactions were assessed by 1) standard morphometry and 2) computer-assisted morphometry.
Standard morphometry was used to quantify percent surface coverage with platelets (percent platelet adhesion) and percent surface coverage with fibrin on collagen (percent fibrin deposition) at 10-/nm intervals along the surface. This technique has been previously described. 21 Computer-assisted morphometry with an IBM computer and DIASYS program (Heinz Meyer, DataLab, Thorigen, Switzerland) was used to quantify the average thrombus height (microns) and thrombus area (square microns per micron of sectional length). Thrombus volume (cubic microns per square microns) was derived from the sectional thrombus area. 15 '
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Histological Examinations of Coronary Arteries
In five separate experiments, immediately after mechanical dislodgement of the coronary thrombus the animals were killed with an intravenous bolus of KC1, and the stenotic part of the circumflex coronary artery was perfusion fixed with 2.5% glutaraldehyde/ 0.1 M cacodylate (pH 7.4) at 100 mm Hg for 15 minutes. The coronary segment was kept overnight in 7% sucrose/0.1 M cacodylate, postfixed in 2.0% OsO 4 , dehydrated in ethanol, and embedded in Epon. Sections were prepared every 150 ^im and stained with toluidine blue and basic fuchsin. Areas of the prestenotic lumen and 13 sections of the stenotic segment were measured planimetrically (DIASYS system). Maximal wall shear rate (y), blood flow velocity (V), and Reynolds number (Re) were determined by assuming well-developed laminar tube flow according to the formulas where Q is coronary blood flow and r is the radius of the stenotic section. The radius is taken as equivalent to a cylindrical tube with the minimal area produced in the stenotic lesion, as determined by planimetric morphology, and
where r is the radius of the stenotic section, V is average blood flow velocity, p is blood density, and 77 is blood viscosity.
Statistical Analysis
All values are expressed as mean±SEM. An analysis of variance test was used to assess differences in morphometric and physiological parameters between groups. A Newman-Keuls test was used to compare parameters within one group at various times. At comparable times an unpaired / test was used to compare the two groups. A probability value less than 0.05 was considered significant.
Results
Hemodynamic Parameters, In Vivo Thrombosis, and Bleeding Time
Baseline systemic arterial pressures, heart rate, and maximum dP/dt before and after generation of the CFRs remained stable throughout the experiment and were unchanged after aspirin (Table 1) . Compared with values during chamber 1, epinephrine increased blood pressure and dP/dt by 28% and 75%, respectively (/?<0.05).
After the circumflex artery constriction was induced and the hyperemic response to a total brief occlusion was abolished, coronary blood flow was reduced by 37±10% of control (/><0.01). All dogs showed CFRs with a flow reduction rate (slope) that did not change significantly in control animals throughout the 1-hour experiment (Figure 2 ). Aspirin abolished the CFRs within 2 minutes in all dogs tested, as typically shown in Figure 3A . Abolition of CFRs by aspirin was accompanied by a 35% increase in coronary blood flow. The abolition of CFRs was maintained even after further reducing blood flow to dp / dt ( 
FIGURE 3. Tracings showing phasic (ml/min) and mean coronary (ml/min) blood flows in a typical experiment after induction of a coronary stenosis. Panel A: Blood flows spontaneously decreased as platelets accumulated but was normalized within a few minutes by a bolus of aspirin (ASA) 10 mglkg i.v. (arrow) and remained unchanged for at least 2 hours without further intervention. Panel B: When aspirin administration was followed by an infusion of 10 fig/min epinephrine (double arrow), however, cyclic flow reductions were again generated.
30% of the unrestrained values, which ruled out any confounding effect of the changes of blood flow on CFRs («=3). Aspirin increased the bleeding time from 120±ll seconds to 170±60 seconds (/><0.05). Platelet count and hematocrit remained unchanged during the experiment (data not shown). Epinephrine restored the aspirin-inhibited CFRs in all six dogs tested (Table 1 and Figure 3B ).
In Vitro Platelet Aggregation
Aspirin produced a profound inhibition (/><0.01) of collagen-induced platelet aggregation (Figure 4 ) in citrated platelet-rich plasma but had no effect on ADP-induced platelet aggregation (not shown).
Ex Vivo Thrombosis
In group 1 (control), ex vivo perfusions performed at 30 and 60 minutes after initiation of the CFRs showed similar values of platelet adhesion, thrombus volume, and fibrin deposition ( Table 2) . In group 2, aspirin reduced the thrombus volume by 84% (p<0.05), without any apparent effect on platelet adhesion and fibrin deposition. This ex vivo effect was concomitant with the disappearance of the CFRs (Table 1 and Figure 3A) .
Epinephrine infusion after aspirin administration restored the thrombus growth in the perfusion chamber (Table 2) concomitantly with the reappearance of CFRs (Table 1 and Figure 3B ). Platelet adhesion and fibrin deposition were not affected by epinephrine. Figure 5 shows representative light photomicrographs of the thrombotic deposits before aspirin ( Figure 5A ), after aspirin ( Figure 5B ), and after aspirin plus epinephrine ( Figure 5C ). Note the loosely packed platelets in the small thrombi after aspirin administration. (Table 3) , and the CFRs generated were identical to the previous ones. The circumferential dimensions were quite irregular due to the constrictive effects of the ring (not shown) and reached an average maximal stenotic area of 5% of the nonstenotic area (Table 3 and Figure 6 ). However, the three-dimensional flow characteristics in such areas cannot be quantitatively described due to both the irregularities of the wall and the changes in crosssectional area. The area initially decreased and then increased with respect to axial position. Qualitatively, one could expect an accelerating velocity profile in the initial half of the constrictive device, followed by a deceleration of velocity, accompanied by the formation of a recirculation (separation) region, in the vicinity of the outlet of the stenosis. It was not clear whether such a recirculation pattern would form at the inlet of the constrictive device. An order of magnitude estimate of the maximum Reynold's number and wall shear rate in the device could be determined from the assumption of fully developed flow in a cylindrical tube, whose area equals that of the maximum constriction. For such a situation the Reynold's number was about 360 and mean wall shear rate, approximately 40,000 (Table 3 and "Appendix").
Discussion
In the present study, an investigation of the influence of stenotic constriction on thrombus development in a coronary artery and its influence on subsequent blood flow, we have directly compared 1) an in vivo system developed by Folts et al 8 and 2) an ex vivo perfusion system designed to simulate the thrombotic events under more controlled conditions of blood flow and surface characteristics. 14 We have demonstrated that thrombosis quantified in the ex vivo thrombosis model parallels the CFR observed in the in vivo thrombosis model.
Much useful information about thrombogenesis has been provided by the Folts model 822 and ex vivo thrombosis models. 14, 21, 23, 24 However, simultaneous comparison of the thrombotic response of in vivo and ex vivo models are lacking. Such information is of critical importance for determining the pathophysiological relevance of the ex vivo models. The effects of aspirin and epinephrine on thrombus formation in the in vivo model have been previously described 13 and were used presently to investigate more precisely its ex vivo behavior. Values are mean±SEM. Perfusions were for 5 minutes at a shear rate of 1,600 sec" We confirmed that aspirin abolished the CFRs in dogs within 2 minutes after intravenous injection and also prolonged the bleeding time significantly. The abolition of CFRs lasted at least 1 hour unless epinephrine was added. It is now established that the CFRs in the Folts model have a platelet origin and result from intracoronary release of serotonin and thromboxane A2. 25 
"
28 It was previously suggested that these mediators were responsible for in vivo platelet aggregation because combined serotonin and thromboxane antagonists abolished the CFRs in the dog.25-28 indeed, a temporal relation between the development of unstable angina and an increase in transcardiac thromboxane concentration supports the contention that intracoronary platelet activation is an important factor in the pathogenesis of unstable angina. 34 Ex vivo thrombus formation and in vitro platelet aggregation were virtually abolished, indicating that aspirin interrupted thrombogenesis in dogs by inhibiting platelet-platelet interaction. Platelet adhesion and the relatively low fibrin deposition were, in contrast, not affected, similar to previous findings in humans. 29 The inhibitory effect of aspirin on CFRs and ex vivo thrombus formation was overcome by infusion of epinephrine. Development of CFRs and restoration of thrombus volume occurred concomitantly and within 10 minutes of epinephrine infusion. This phenomenon has been related to a stimulatory effect of epinephrine in platelets, which bypasses cyclooxygenase inhibition. 13 - 30 Thus, it appears that the modulating effects of aspirin and epinephrine on in vivo thrombus formation are paralleled in the ex vivo model.
The shear rate, which has a profound effect on thrombogenesis, 723 was more than one order of magnitude greater in this model than that encoun- Coronary dimensions, flow rates, and calculated maximum wall shear rate were derived from morphometric analysis of coronary sections from five dogs, proximal to the stenosis (normal surface) and within the stenosis (stenosed segment). The wall shear rates, y : in nonstenotic segments and y 2 in stenotic segments, were calculated according to the formula given in "Methods" and assuming steady laminar flow at the narrowest section of the lumen (see "Methods").
tered under normal physiological conditions. 2331 Such high shear rates are assumed to be present in severely stenosed arteries. 31 Our calculated shear rate values shown in Table 3 may be somewhat overestimated, as we did not account for vessel shrinkage due to dehydration. Indeed, shrinkage may reduce the vessel lumen by 16%, and when this factor is taken into account would have decreased the calculated stenotic shear rate from 15,000-64,000 to 9,000-40,000 sec" 1 . With such a correction the average nonstenotic shear rate would be decreased from 400 to 260 sec" 1 , a value that is within the range of experimentally measured shear rates in the circumflex coronary artery of normal dogs 32 or in moderately stenosed human coronary arteries. 33 While wall shear rates (and concomitantly, shear stresses) have been studied extensively over the physiological range (up to 10,000 sec" 1 ), few perfusion studies have been conducted at these high-shear conditions or perhaps, more importantly, in flow situations in which high shear and complex recirculation patterns (lower shear) are encountered in close proximity, such as might occur in advanced stenosis. A recent report has indicated that platelet deposition on vascular media placed in such a constricted geometry occurs predominantly at the apex of the stenotic region, that is, in the high-shear area. 34 In the present experiments these high in vivo shear rates are obtained by a 95% narrowing of the coronary artery, a degree of obstruction greater than that initially described by Folts et al. 8 Matching the ex vivo with the high in vivo shear rates in the stenoses would have been difficult with use of the available parallel flow chambers because the high flow rates needed to reach the in vivo shear rates would probably have impaired canine hemodynamics. The relatively large in vivo variation was presumably introduced by individual variation in luminal diameter and wall thickness and the reproducibility of the constriction.
Thus, simultaneous comparison of thrombus formation in the two models showed that modulation of platelet function by aspirin and epinephrine affected the thrombotic process similarly in vivo and ex vivo. However, one should notice that aspirin has not been shown to be equally successful in all in vivo 9 -1735 - 39 or ex vivo 29 -40 models of thrombosis. The inhibitory effect of aspirin obviously depends on the animal species used, the various means to induce thrombosis, and local conditions, that is, shear rate and thrombogenic surface, as discussed above. The in vivo models potentially offer a more immediate relevance to thrombotic events that occur intravascularly. However, the in vivo models are difficult to control in that they offer limited means of varying their characteristics to test suspected biologic mechanisms. In addition, analysis is often limited to indirect and often end-point observations of thrombotic events.
In conclusion, our study shows that the ex vivo device appears to reflect the in vivo situation, at least at high-shear conditions, and brings more detailed insight about compounds interfering with thrombus formation. Considerable additional work is needed to understand the local fluid dynamics and transport phenomena in complex stenosis, as well as to quantify the mechanisms by which platelets and fibrin are deposited in the various low-and high-shear flow areas. thanked for expert technical assistance, and J. Lobsiger is thanked for typing the manuscript.
Appendix
Estimation of In Vivo Reynolds Number (Re) and Shear Rate (y)
where D is the diameter of the stenotic vessel estimated as (4AJv) m , V is the blood flow velocity (Q/A), p is blood density, r\ is blood viscosity, Q is blood flow rate, and A is stenotic surface area.
The entrance length for a circular tube can be estimated as Le=0.05ReD=9mm which is well in excess of the length of the constriction. Thus, the velocity profile even for a tube of constant diameter will not be fully developed. Consequently, calculations for local shear conditions are somewhat conservative in that the velocity gradient at the wall will be even greater than that for fully developed flow.
